日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical evaluation of CAR-T cell immunotherapy with a fully human EpCAM-specific scFv against pancreatic cancer.

采用全人源EpCAM特异性scFv的CAR-T细胞免疫疗法治疗胰腺癌的临床前评估。

Fan Ying-Ying, Liu Ya-Ling, Liu Xiao-Fan, Jiang Si-Qi, Yang Hui, Zhang Hao-Ran, Wei Ping, Huang Qian-Rong

The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort

MCM3在泛癌中的预后和免疫学作用及其在临床低级别胶质瘤队列中的预后验证

Huang, Qian-Rong; Jiang, Qian; Tan, Ju-Yuan; Nong, Ren-Bao; Yan, Jun; Yang, Xia-Wei; Mo, Li-Gen; Ling, Guo-Yuan; Deng, Teng; Gong, Yi-Zhen

Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma.

胶质瘤中二硫键断裂相关基因和分子亚型的预后风险评分的鉴定

Jiang Qian, Ling Guo-Yuan, Yan Jun, Tan Ju-Yuan, Nong Ren-Bao, Li Jian-Wen, Deng Teng, Mo Li-Gen, Huang Qian-Rong

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma

建立和验证与铁死亡相关的lncRNA特征用于低级别胶质瘤的预后预测

Huang, Qian-Rong; Li, Jian-Wen; Yan, Ping; Jiang, Qian; Guo, Fang-Zhou; Zhao, Yin-Nong; Mo, Li-Gen

A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma

一种包含6种RNA结合蛋白的新型风险特征用于胶质母细胞瘤患者的预后预测

Huang, Qian-Rong; Li, Jian-Wen; Pan, Xin-Bin